After years of development, my country's biological industry has already had a good foundation, which is reflected in the continuous improvement of biotechnology level and the acceleration of technological industrialization.

After years of development, my country's biological industry has already had a good foundation, which is reflected in the continuous improvement of biotechnology level and the acceleration of technological industrialization. Although there is still a lot of gap with the international advanced level, the biotechnology industry has become an important part of the country's strategic emerging industries and will be strongly tilted by national policies in the future. The future prospects of the biotechnology industry will be very broad.

Overall Overview of the Biotechnology Industry

Under the guidance and promotion of national policies, my country's biological industry has entered a stage of rapid development since 2000, with the average annual growth of industrial product sales revenue from 2000 to 2008 reaching 20.45%. In 2008, the total output value of my country's biotechnology industry reached nearly 250 billion yuan, and the total scale of the biotechnology industry reached nearly 1.1 trillion yuan (of which, the output value of the bioindustry bases in 22 countries reached 722 billion yuan, accounting for nearly 66% of the national bioindustry output value); in 2015, the total scale of China's biotechnology industry reached nearly 700 billion yuan.

Scale and growth of China's biotechnology industry from 2006 to 2015 (unit: billion yuan, %)

Source: "Foresight Industry Research Institute Biotechnology Industry Report"

In China's biotechnology industry, the output value of biomedicine is the highest, reaching 297.9 billion yuan in 2015, accounting for 43.2%; in 2015, the market size of bioagriculture and biomanufacturing was 187.4 billion yuan and 160.5 billion yuan, respectively, accounting for 27.2% and 23.3% respectively.

2015 China's biotechnology industry industrial structure (unit: %)

Source: "Foresight Industry Research Institute Biotechnology Industry Report"

Although China's biotechnology industry has a good foundation after years of development, there are still many gaps compared with the biochemical industry of advanced countries in the world. The development of China's biochemical industry will be a difficult road from scientific research to industrialization. Despite some adverse factors, the development prospects of China's biochemical industry will be very broad due to the improvement of domestic biotechnology level and the acceleration of the industrialization of related technologies.

is expected to continue to develop rapidly from 2016 to 2022, with a compound growth rate of around 15%. By 2020, the scale of China's biotechnology industry will reach about 1.5 trillion yuan.

2015-2022 China's biotechnology industry scale and forecast (unit: billion yuan)

Source: "Foresight Industry Research Institute Biotechnology Industry Report"

Development trend of biotechnology industry

First of all, the increase in cross-border integration between industries is mainly due to the increasing division between industries and industries, and cooperation between enterprises will increase. At present, many companies engaged in pharmaceutical, agriculture, environment, energy and other aspects are engaged in biotechnology production. In particular, some manufacturers engaged in the traditional chemical industry have also entered the field of biotechnology.

Secondly, there are frequent R&D cooperation among enterprises. Because biotechnology involves a wide range of areas, many biochemical companies have their own expertise, and their cooperation for commercial interests is also very active. In addition, with the addition of manufacturers engaged in traditional industries, they cooperate frequently with companies engaged in biotechnology development and production due to technical and production reasons. All of this makes the cooperation in the biotech industry more and more extensive.

Again, technology research and development is still the focus. Continuously improving the vitality, fermentation level, biochemical reaction process, and isolation and purification level is still a problem facing biotechnology. In terms of strain development, it will be considered to use known strains to produce new products after appropriately changing their metabolic characteristics; in terms of biochemical reactors, computer technology is used to digitally process the entire biochemical reaction process to optimize the reaction process; in terms of separation and purification, affinity chromatography has been widely paid attention to. In terms of isolation and purification, affinity chromatography has received widespread attention. Finally, the development of upstream biological technologies will have a profound impact on biotechnology. People attach great importance to the sequential determination of human genome from viruses, bacteria, plants, animals to , and on this basis, many genes have rushed forward, blindly launched, blooming everywhere, eventually forming vicious competition, and many companies went bankrupt.Companies that survived the competition were also severely damaged and it was difficult to further organize technological transformation.